David P Light

US Patent:

43608485, Nov 23, 1982

Filed:

Jun 18, 1980

Appl. No.:

6/160685

Inventors:

Theodore E. Noutko - Brighton MI
Steve D. Toms - Howell MI
David P. Light - Howell MI

International Classification:

H02H 716

US Classification:

361 15

Abstract:

A protective assembly is provided for a power capacitor having three electrical terminals extending outwardly from the top of the capacitor. The protective assembly comprises a mounting plate constructed of an electrical insulating material having three holes formed through it which register with the electrical terminals of the capacitor. The mounting plate is positioned over the capacitor terminals so that the lower side of the mounting plate faces the top of the capacitor while the electrical terminals protrude outwardly from the upper side of the mounting plate. Bleed resistors are connected between each pair of the capacitor terminals on the upper side of the plate. In addition, a fuse assembly is attached to the upper side of the mounting plate and has at least one and preferably three fuse holders. Each capacitor terminal is connected to one of the fuse holders on the fuse assembly while the other terminal for each fuse holder forms the power connection to the electrical load.

US Patent:

48915696, Jan 2, 1990

Filed:

Aug 20, 1982

Appl. No.:

6/409930

Inventors:

David P. Light - Howell MI

Assignee:

Versatex Industries - Brighton MI

International Classification:

G05F 170

US Classification:

323210

Abstract:

In a computer controlled power factor control system switches are activated and deactivated in a predetermined order so that each capacitor is electrically connected to the power distribution system for substantially the same total time throughout the life of the capacitors.

US Patent:

20170216434, Aug 3, 2017

Filed:

Aug 5, 2015

Appl. No.:

15/501731

Inventors:

- Detroit MI, US
- Cambridge MA, US
Jennell C. Jackson - Detroit MI, US
Sriram Krishnamoorthy - Somerville MA, US
David R. Light - Cambridge MA, US

International Classification:

A61K 39/395
G01N 33/564
A61K 31/17

Abstract:

This invention relates to methods of treating sickle cell disease with VLA-4 antagonists and methods for evaluating the responsiveness of patients having sickle cell disease to treatment with VLA-4 antagonists.